CatalystPit

CLDICalidi Biotherapeutics, Inc.

AMEX · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.07 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$2.77M
CountryUSA
RECENT INSIDER TRADES
  • 2025-12-16 · Camaisa Allan (Director) · SELL
  • 2025-08-25 · Poma Eric E (Chief Executive Officer) · BUY
  • 2025-08-25 · Jackson Andrew C. (Chief Financial Officer) · BUY
  • 2025-08-25 · Schoeneck James A (Director) · BUY
  • 2025-08-25 · Leftwich Scott (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders26
Shares held572,862
Value$130.50K
Percent of shares outstanding22.17%
As of quarter end2026-06-30
RECENT NEWS
  • Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
  • Calidi Biotherapeutics receives NYSE American notice for stockholders' equity deficiency
  • Calidi Biotherapeutics raises $1.2 million in registered direct offering
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Calidi Biotherapeutics, Inc. (CLDI) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit